Applicant, as named in the Orange Book

Eagle Pharms

Next listed expiry: Belrapzo on 11 Aug 2031. 3 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Belrapzo NDA 205580 bendamustine hydrochloride	bendamustine hydrochloride	11 Aug 2031 patent	patent
Bendeka NDA 208194 bendamustine hydrochloride	bendamustine hydrochloride	15 Mar 2033 patent, carve-out possible	patent, carve-out possible
Pemfexy NDA 209472 pemetrexed	pemetrexed	19 Feb 2036 patent	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (1)

Drug	Ingredient	Earliest generic entry	Basis
Ryanodex NDA 205579 dantrolene sodium	dantrolene sodium	open now no listed protection	no listed protection